Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study
| Image |  |
|---|---|
| Description | scientific article published on 21 September 2017 |
| Author/s |
author: Irit Avivi Pieternella J Lugtenburg Michael Pfreundschuh |
| Publication date | September 21, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |